Ironwood IRWD announced that the FDA has approved Linzess (linaclotide) as a once-daily treatment for functional constipation in pediatric patients aged 6-17 years. This approval for the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback